Late onset dominant cone dystrophy
Late Onset Dominant Cone Dystrophy (LODCD) is a rare eye disease characterized by the progressive loss of cone cells, which are responsible for color vision and central visual acuity. This condition typically manifests in adulthood, leading to a gradual decline in the ability to see colors and fine details. Unlike some other forms of cone dystrophy, LODCD is inherited in an autosomal dominant manner, meaning that only one copy of the mutated gene from an affected parent is sufficient to cause the disorder.
Symptoms[edit | edit source]
The primary symptoms of Late Onset Dominant Cone Dystrophy include:
- Loss of color vision
- Decreased visual acuity
- Increased sensitivity to light (photophobia)
- Central vision loss
These symptoms typically begin in adulthood, with the degree and progression of vision loss varying widely among affected individuals.
Causes[edit | edit source]
LODCD is caused by genetic mutations that affect the function of the cone cells in the retina. The specific genes involved can vary, but mutations in the GUCY2D gene are among the most commonly identified causes. This gene plays a crucial role in the phototransduction pathway, which is essential for converting light into electrical signals in the retina.
Diagnosis[edit | edit source]
Diagnosis of Late Onset Dominant Cone Dystrophy involves a comprehensive eye examination, including:
- Detailed medical and family history
- Visual acuity test
- Color vision testing
- Electroretinogram (ERG) to measure the electrical responses of the retina's light-sensitive cells
- Optical coherence tomography (OCT) to obtain detailed images of the retina
Treatment[edit | edit source]
There is currently no cure for LODCD, and treatment focuses on managing symptoms and improving quality of life. Options may include:
- Use of corrective lenses
- Low vision aids
- Counseling and support to adjust to changes in vision
Prognosis[edit | edit source]
The prognosis for individuals with Late Onset Dominant Cone Dystrophy varies. While the condition typically leads to progressive vision loss, the rate and extent of deterioration differ among patients. Many individuals maintain functional vision well into adulthood.
Research[edit | edit source]
Research efforts are ongoing to better understand the genetic basis of LODCD and to develop potential treatments. Gene therapy, which aims to correct the underlying genetic defects causing the disease, represents a promising area of investigation.
Late onset dominant cone dystrophy Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD